Crohn'S/colitis Enrollment Form

Download a blank fillable Crohn'S/colitis Enrollment Form in PDF format just by clicking the "DOWNLOAD PDF" button.

Open the file in any PDF-viewing software. Adobe Reader or any alternative for Windows or MacOS are required to access and complete fillable content.

Complete Crohn'S/colitis Enrollment Form with your personal data - all interactive fields are highlighted in places where you should type, access drop-down lists or select multiple-choice options.

Some fillable PDF-files have the option of saving the completed form that contains your own data for later use or sending it out straight away.

ADVERTISEMENT

Crohn’s / Colitis Enrollment Form
Patients must bring an original prescription to the pharmacy. Faxed prescriptions will only be accepted from a prescribing practitioner.
PATIENT INFORMATION
PRESCRIBER INFORMATION
1
)
(
Complete the following or include demographic sheet
Name:
State License #:
NPI #:
Patient Name:
DEA #:
Address:
City, State, Zip :
Group or Hospital:
Primary Phone:
DOB:
Address:
City, State Zip:
Alternate Phone:
Phone:
Fax:
Gender:
Male
Female
Primary Language:
Contact Person:
Phone:
INSURANCE INFORMATION
If available, please fax copy of prescription insurance cards with this form (front and back).
MEDICAL INFORMATION
Reason for Discontinuing
4
Prior Failed Medication(s):
Length of Treatment
_____/_____/_ _____ -_____/_____/_______
5-ASA
Corticosteroids
_____/_____/_ _____ -_____/_____/_______
Immunosuppressants (6-MP or other)
_____/_____/_ _____ -_____/_____/_______
Methotrexate
Other
Date of Diagnosis: ______/______/_ ______
TB/PPD Test Results:
Prior biologic use: Date of last dose:
Negative
K50.00 Regional enteritis of small intestine
Remicade®
______________
Positive
K50.10 Regional enteritis of large intestine
Humira®
_______________
Hepatitis B ruled out or being treated:
Regional enteritis of small intestine with large intestine
K50.80
Simponi®
______________
Yes
K50.90 Regional enteritis of unspecified site
No
Cimzia®
______________
K51.80 Ulcerative enterocolitis
K51.80 Ulcerative ileocolitis
K51.50 Left-sided ulcerative colitis
Allergies:
K51.00 Universal ulcerative colitis
K51.90 Ulcerative colitis, unspecified
Patient’s Weight:
Other: _ _________________________________________
PRESCRIPTION
Drug
Directions & Quantity
Refills
Cimzia
®
Prefilled Syringe
INITIAL: Inject 400mg SQ on day 1, 14, and 28 (Quantity: 6)
Lyophilized Powder
MAINTENANCE: Inject 400mg SQ every 4 weeks (Quantity: 2)
MAINTENANCE: Inject 200mg SQ every 2 weeks (Quantity: 2)
Humira
®
Crohn’s Starter Kit
INITIAL: Inject 160mg SQ on day 1, then 80mg on day 14 (Quantity: 6)
 
P en
MAINTENANCE: Inject 40mg SQ every other week (Quantity: 2)
 
P re-filled Syringe
Remicade
 
®
V ials
INITIAL: Infuse _ 5 mg /____kg=______mg on day 0, 14, and 42 (Quantity: _____)
MAINTENANCE: Infuse _ ____ mg every 8 weeks (Quantity: _____)
Simponi
 
®
S martJect® (Pen)
INITIAL: Inject 200mg SQ on day 1, then 100mg on day 14 (Quantity: 3)
 
P re-filled Syringe
MAINTENANCE: Inject 100mg SQ every 4 weeks (Quantity: 1)
INITIAL / MAINTENANCE : Week zero two and six
Entyvio
®
300mg in 20 mL V ial
weeks, then every eight weeks thereafter
INJECTION TRAINING
Patient has received pen and injection training
Physician’s office to provide injection training
Pharmacy t o coordinate injection training or infusion
PHYSICIAN SIGNATURE
To Physician: By signing this form and utilizing our services, you are also authorizing pharmacy to serve as your prior authorization agent in dealing with medical and prescription insurance companies,
and co-pay assistance foundations.
Physician
Signature:
Date:
_ ________________________
IMPORTANT NOTICE: This facsimile transmission is intended to be delivered only to the named addressee and may contain material that is confidential, privileged, proprietary or exempt from disclosure under
applicable law. If it is received by anyone other than the named addressee, the recipient should immediately notify the sender at the address and telephone number set forth herein and obtain instructions as
to disposal of the transmitted material. In no event should such material be read or retained by anyone other than the named addressee, except by express authority of the sender to the named addressee.

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go